Literature DB >> 27193782

Role of Pericellular Matrix in the Regulation of Cancer Stemness.

Sofia Avnet1, Margherita Cortini2,3.   

Abstract

Cancer stem cells (CSC) are a prominent component of the tumor bulk and extensive research has now identified them as the subpopulation responsible for tumor relapse and resistance to anti-cancer treatments. Surrounding the bulk formed of tumor cells, an extracellular matrix contributes to cancer growth; the main component of the tumor micro-environment is hyaluronan, a large disaccharide forming a molecular network surrounding the cells. The hyaluronan-dependent coat can regulate cell division and motility in cancer progression and metastasis. One of the receptors of hyaluronan is CD44, a surface protein frequently used as a CSC marker. Indeed, tumor cells with high levels of CD44 appear to exhibit CSC properties and are characterized by elevated relapse rate. The CD44-hyaluronan-dependent interactions are Janus-faced: on one side, they have been shown to be crucial in both malignancy and resistance to therapy; on the other, they represent a potential value for future therapies, as disturbing the CD44-hyaluronan axis would not only impair the pericellular matrix but also the subpopulation of self-renewing oncogenic cells. Here, we will review the key roles of HA and CD44 in CSC maintenance and propagation and will show that CSC-like spheroids from a rabdhomyosarcoma cell line, namely RD, have a prominent pericellular coat necessary for sphere formation and for elevated migration. Thus, a better understanding of the hyaluronan-CD44 interactions holds the potential for ameliorating current cancer therapies and eradicating CSC.

Entities:  

Keywords:  CD44; Cancer stem cell; Hyaluronan; Pericellular matrix; Sarcoma

Mesh:

Substances:

Year:  2016        PMID: 27193782     DOI: 10.1007/s12015-016-9660-x

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  133 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.

Authors:  Peng Li; Tingxiu Xiang; Hongzhong Li; Qianqian Li; Bing Yang; Jing Huang; Xiang Zhang; Yuan Shi; Jinxiang Tan; Guosheng Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.

Authors:  Shivani Rai Paliwal; Rishi Paliwal; Govind Prasad Agrawal; Suresh Prasad Vyas
Journal:  J Liposome Res       Date:  2016-01-19       Impact factor: 3.648

4.  CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.

Authors:  Alba Rocco; Eleonora Liguori; Giuseppe Pirozzi; Virginia Tirino; Debora Compare; Renato Franco; Fabiana Tatangelo; Raffaele Palaia; Francesco Paolo D'Armiento; Giorgia Pollastrone; Andrea Affuso; Enrico Coppola Bottazzi; Stefania Masone; Giovanni Persico; Gerardo Nardone
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 6.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.

Authors:  Shibnath Ghatak; Suniti Misra; Bryan P Toole
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

Review 8.  The glycocalyx and its significance in human medicine.

Authors:  J M Tarbell; L M Cancel
Journal:  J Intern Med       Date:  2016-01-08       Impact factor: 8.989

9.  A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.

Authors:  Joan Fernando; Andrea Malfettone; Edgar B Cepeda; Roser Vilarrasa-Blasi; Esther Bertran; Giulia Raimondi; Àngels Fabra; Alberto Alvarez-Barrientos; Pedro Fernández-Salguero; Conrado M Fernández-Rodríguez; Gianluigi Giannelli; Patricia Sancho; Isabel Fabregat
Journal:  Int J Cancer       Date:  2014-08-04       Impact factor: 7.396

Review 10.  CD44v6: a target for antibody-based cancer therapy.

Authors:  Karl-Heinz Heider; Hartmut Kuthan; Gerd Stehle; Gerd Munzert
Journal:  Cancer Immunol Immunother       Date:  2004-02-05       Impact factor: 6.968

View more
  8 in total

1.  In vitro elucidation of the role of pericellular matrix in metastatic extravasation and invasion of breast carcinoma cells.

Authors:  Marie-Elena Brett; Heather E Bomberger; Geneva R Doak; Matthew A Price; James B McCarthy; David K Wood
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

Review 2.  Provisional matrix: A role for versican and hyaluronan.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2016-12-06       Impact factor: 11.583

Review 3.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

Review 4.  CD44 In Sarcomas: A Comprehensive Review and Future Perspectives.

Authors:  Enrique Fernández-Tabanera; Raquel M Melero-Fernández de Mera; Javier Alonso
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 5.  Cancer Stem Cells in Soft-Tissue Sarcomas.

Authors:  Paula Martínez-Delgado; Serena Lacerenza; Antonia Obrador-Hevia; Maria Lopez-Alvarez; José L Mondaza-Hernandez; Elena Blanco-Alcaina; Paloma Sanchez-Bustos; Nadia Hindi; David S Moura; Javier Martin-Broto
Journal:  Cells       Date:  2020-06-10       Impact factor: 6.600

Review 6.  Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.

Authors:  Thomas N Wight; Inkyung Kang; Stephen P Evanko; Ingrid A Harten; Mary Y Chang; Oliver M T Pearce; Carys E Allen; Charles W Frevert
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

Review 7.  Effects of biomechanical forces on the biological behavior of cancer stem cells.

Authors:  Bo Ren Tian; Wei Fan Lin; Yan Zhang
Journal:  J Cancer       Date:  2021-08-08       Impact factor: 4.207

8.  Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.

Authors:  Yuyang Tong; Peixuan Sun; Juanjuan Yong; Hongbo Zhang; Yunxia Huang; Yi Guo; Jinhua Yu; Shichong Zhou; Yulong Wang; Yu Wang; Qinghai Ji; Yuanyuan Wang; Cai Chang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.